Insulin degludec

Rarity: Common

The most frequent rarity: most Wikipedia articles become Commons.

Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.

At a glance

Class

Invention

Domain

Science and technology

Knowledge cost

2

In collections

Nobody has pulled it yet.

What Wikipedia says

Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo under the brand name Tresiba. It is administered via subcutaneous injection to help control the blood sugar level of those with diabetes.

Excerpt from the Wikipedia article “Insulin degludec”, under the CC BY-SA 4.0 license. Read the article on Wikipedia

Image: Fvasconcellos (talk · contribs), Public domain, via Wikimedia Commons.